1

AngioDynamics

#7013

Rank

$546.31M

Marketcap

US United States

Country

AngioDynamics
Leadership team

Mr. James C. Clemmer (CEO, Pres & Director)

Mr. Stephen A. Trowbridge (Exec. VP & CFO)

Mr. David D. Helsel (Sr. VP of Global Operations and R&D)

Products/ Services
Biotechnology, Hardware, Health Care, Manufacturing
Number of Employees
500 - 1000
Headquarters
Latham, New York, United States
Established
1992
Company Registration
SEC CIK number: 0001275187
Revenue
100M - 500M
Traded as
ANGO
Social Media
Overview
Location
Summary
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
History

AngioDynamics was founded in 1988 by Dr. Ethan Singer and Bob Hughes in order to provide innovative medical device solutions. The company has grown over the years and currently has facilities around the world and produces a full line of products and services that increase patient quality of life.

Mission
At AngioDynamics, our mission is to improve the quality of life and well-being of patients with innovative, minimally invasive and cost-effective medical devices.
Vision
Our vision is to become the preferred global medical device partner, dedicated to providing best-in-class medical devices that enhance patient quality of life.
Key Team

Mr. Benjamin H. Davis (Sr. VP of Bus. Devel.)

Ms. Marna I. Bronfen-Moore (Sr. VP of HR)

Mr. Chad T. Campbell (Sr. VP & GM of Vascular Access Global Bus. Unit)

Mr. Warren G. Nighan (Sr. VP of Quality & Regulatory Affairs)

Ms. Laura Piccinini (Sr. VP & GM of International)

Ms. Kim L. Seabury (Sr. VP of Information Technology)

Mr. Richard C. Rosenzweig (Sr. VP, Gen. Counsel & Company Sec.)

Recognition and Awards
AngioDynamics has received various awards for its innovation and dedication to improving patient quality of life, such as being named a Medtech Breakthrough Award Winner in 2019, as well as being listed as one of the World’s Most Innovative Companies in Medtech by Fast Company.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

AngioDynamics
Leadership team

Mr. James C. Clemmer (CEO, Pres & Director)

Mr. Stephen A. Trowbridge (Exec. VP & CFO)

Mr. David D. Helsel (Sr. VP of Global Operations and R&D)

Products/ Services
Biotechnology, Hardware, Health Care, Manufacturing
Number of Employees
500 - 1000
Headquarters
Latham, New York, United States
Established
1992
Company Registration
SEC CIK number: 0001275187
Revenue
100M - 500M
Traded as
ANGO
Social Media